Home / Feed
Insights
News
Jobs
Have questions, feedback, or partnership inquiries? Our team is always happy to connect and assist you.
Contact
Whatsapp
Sign In
Theme
Sign Up
Circuit News
Loading
This may take few seconds...
News | Corporate Social
Last updated:
1 min ago
0
stories today
Page 1 of 2
Bloom43’s Prehabilitation Model Is Redefining Breast Surgery Preparation
Bloom43 is transforming breast surgery preparation with a prehabilitation platform that combines a wearable medical device and guided digital support. By strengthening tissue resilience before surgery and empowering patients through an 8-week companion program, Bloom43 is improving recovery, reducing complications, and redefining how modern surgical care begins, long before the first incision.
MedTech
Healthcare Innovation
Digital Health
Patient-Centered Care
3 mins read
Source
0
38
0
0
Zoho-Backed VoxelGrids Builds India’s First Indigenous MRI Scanner
VoxelGrids, backed by Zoho, has deployed India’s first indigenously designed and manufactured 1.5T MRI scanner at the Chandrapur Cancer Care Foundation near Nagpur. Built through over a decade of R and D, the system claims major cost advantages by eliminating liquid helium, and the company is now developing a containerised mobile MRI to expand diagnostic access in remote regions.
Lifesciences
MedTech
Indigenous innovation
Diagnostic imaging
3 mins read
Source
0
88
0
0
Emerald Cloud Lab’s Revolutionary Approach to Remote Research is Reshaping Life Sciences
Emerald Cloud Lab (ECL) is revolutionizing life sciences research with its cloud-based, fully automated platform, enabling scientists to conduct experiments remotely without traditional lab spaces. By offering access to high-end instruments and automating routine tasks, ECL is democratizing research, accelerating scientific discovery, and expanding global collaboration. With plans to integrate AI and scale internationally, ECL is paving the way for faster, more efficient advancements in biotech and pharmaceuticals.
4 mins read
Source
0
92
0
0
Liquidia’s Next Move Is Not A New Molecule. It Is A Longer-acting Treprostinil Designed To Reduce Dosing Frequency.
Liquidia’s L606 is a clear bet that the next leap in inhaled pulmonary hypertension therapy will come from making treprostinil easier to sustain, not from reinventing the molecule. The real proof will be whether extended exposure translates into better titration, adherence, and durable outcomes in everyday clinical use.
LifeSciences
MedTech
Medicaldevice
PulmonaryHypertension
DrugDelivery
4 mins read
Source
0
38
0
0
Symvess Introduces a New Kind of Vascular Conduit Built for Host Remodeling
Symvess signals a shift in vascular repair from permanent synthetic grafts toward acellular, tissue engineered conduits designed for host remodeling. By retaining an extracellular matrix “tissue frame,” the approach aims to support integration while reducing long-term foreign body complications. FDA approval makes this a validated clinical category, not just an experimental idea. The key questions now are consistency across real-world patients and sites, and long-horizon durability once remodeling is established.
Lifesiences
MedTech
Regenerativemedicine
Medicaldevice
Vascularsurgery
2 mins read
Source
0
78
0
0
Transformative Vascular Implants Are Starting to Look Less Like Permanent Plumbing and More Like Guided Healing.
Vascular implants are shifting from permanent synthetic grafts to biorestorative scaffolds that are replaced by the patient’s own tissue. Xeltis is leading this trend, with its aXess EU hemodialysis trial (120 patients, 18 sites) showing strong patency and low complications across 15,000 plus dialysis sessions. The key unknowns are real world consistency and long term failure modes after the scaffold fully resorbs.
MedTech
HealthcareInnovation
VascularImplants
2 mins read
Source
0
106
0
0
Nanopath’s 15-Minute Molecular Test Could Reset the Global Standard for UTI Diagnostics
Current UTI diagnostics cause lengthy waits and drive antimicrobial resistance through broad-spectrum antibiotic use. Nanopath's groundbreaking 15-minute molecular diagnostic platform is resetting this standard, quickly identifying pathogens and resistance markers directly from urine at the point of care. This innovation promises to deliver precise treatment immediately, drastically improving patient care and combating global antimicrobial resistance.
WomensHealth
InfectiousDisease
PointOfCareTesting
3 mins read
Source
0
84
0
0
Mytos Brings Robotic Scale to Human Cell Manufacturing, Targeting a 1,000x Capacity Gap
Mytos is deploying robotic platforms to manufacture human cells at an industrial scale, closing the critical 1,000x capacity gap in regenerative medicine. By automating the transformation of pluripotent stem cells into specialized cells, Mytos aims to scale breakthrough therapies for diseases like Parkinson's and Type 1 diabetes to routine patient care. This promises repeatable, GMP-friendly workflows and a significant reduction in cost per cell, enabling access for millions.
Stemcellresearch
MedTech
Biomanufacturing
Healthtech
SyntheticBiology
3 mins read
Source
0
54
0
0
BrainCo’s Bionic Hand: A Non-Invasive Leap Toward Practical, Affordable Neuroprosthetics
BrainCo has unveiled a significant leap in neuroprosthetics with a bionic hand that controls affordable prosthetic limbs using non-invasive nerve and muscle signals. This breakthrough eliminates the need for brain implant surgery, offering enhanced dexterity, lower costs, and quicker training times to make advanced prosthetic solutions truly practical and accessible for users.
Prosthesis
medicaldevice
neuroprosthetics
implant
device
medicine
4 mins read
Source
0
84
0
0
Healthy.io’s Smartphone Diagnostics Are Quietly Redefining Preventive Healthcare
Healthy.io is quietly redefining preventive healthcare by transforming the smartphone into a certified clinical diagnostic tool. Using AI-powered at-home tests like Minuteful Kidney, the company delivers lab-grade accuracy, dramatically increasing screening rates for conditions such as chronic kidney disease and catching issues earlier to improve outcomes. This innovation collapses access barriers, making crucial diagnostics available on patients' terms.
MedTech
DigitalHealth
AIinHealthcare
3 mins read
Source
0
64
0
0
